NCT01044810View on ClinicalTrials.gov

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

CompletedOBSERVATIONAL
Enrollment

559

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Treatment Failure, HIV or AIDSCD4 Cell Counts
Interventions
DRUG

Efavirenz-based regimens

Efavienz: 600 mg, oral, every 24 hours, continued medication until the end of study.

Trial Locations (1)

11000

Bamrasnaradura Infectious Disease Institute, Nonthaburi

Sponsors
All Listed Sponsors
collaborator

Thai Red Cross AIDS Research Centre

OTHER

collaborator

Clinical Research Collaborative Network

NETWORK

lead

Bamrasnaradura Infectious Diseases Institute

OTHER_GOV